1 Woodlands Road, #02-11, Singapore 677899
212 Hougang Street 21, #01-331, Singapore 530212

Case Study: Approach to Female Hormonal Acne

Hormonal Acne Singapore
Table of Contents

Introduction: Background

Adult female hormonal acne is recognised as a distinct subtype of acne that differs from teenage acne or classic acne vulgaris, not only in its underlying causes but also in its presentation and persistence. It typically affects women over the age of 25 and may either continue from adolescence or appear for the first time in adulthood. Unlike adolescent acne, which often improves with age, hormonal acne can last for many years, sometimes persisting until the post-menopausal period.

Epidemiological studies show that the majority of adult acne patients are women, with an average age of around 35 years. Up to 5% of women between the ages of 40 and 49 may still experience active acne, underscoring its chronic and often frustrating nature. Beyond its physical effects, hormonal acne can also affect emotional well-being, self-confidence and quality of life.

Drawing on more than a decade of clinical experience treating thousands of acne patients across a wide spectrum of severity, we present a real-world case study of a female patient with hormonal acne, outlining her diagnosis, treatment plan, and outcomes.

Hormonal Acne Singapore
Hormonal acne is a type of acne driven by hormonal fluctuations, commonly seen in adult women and often affecting the lower face, jawline, and chin.

 

Patient Presentation: The Story Behind

CA is a 36-year-old female human resource manager who has been experiencing worsening acne since her mid-20s. Her breakouts clearly follow a hormonal pattern, flaring more severely in the week before her menstrual cycle. She reports a history of adolescent acne treated with a course of oral isotretinoin, which provided temporary clearance. In recent years, she has been prescribed courses of oral antibiotics and topical retinoids, but these offered only short-term relief. She is reluctant to restart oral isotretinoin therapy.

CA expresses frustration that she continues to suffer from acne in adulthood and is especially concerned about post-acne scarring. She is otherwise healthy, with no significant medical history, and is not on long-term medications. Family history reveals that both her siblings had acne during adolescence, but their symptoms did not persist into adulthood.

Lifestyle factors play a role: CA is a smoker and notes that stress, certain cosmetic products, and dietary triggers tend to worsen her acne flares.

Physical examination revealed a combination of inflammatory papules, pustules, and comedones along the cheeks, jawline and upper neck, with one acne nodule present. Evidence of post-inflammatory hyperpigmentation, erythema, and atrophic acne scarring was also noted. Importantly, there were no signs of hirsutism (male-pattern hair growth), which may otherwise suggest an underlying endocrine disorder such as polycystic ovarian syndrome (PCOS).

Using the Adult Female Acne Scoring Tool (AFAST), CA’s presentation was graded as Moderate, based on the type and distribution of acneiform lesions across the face and jawline.

Adult Female Acne Scoring Tool (AFAST)

Score 1: Facial Acne Severity

ScoreSeverityFeatures
0No lesionsNo active acne lesions; may show residual pigmentation or erythema
1Almost noneFew open/closed comedones, few papules
2Mild< 50% of face involved; few comedones, papules, pustules
3Moderate> 50% of face involved; numerous comedones, papules, pustules, and up to one nodule
4SevereEntire face involved; numerous comedones, papules, pustules, occasional nodules
5Very severeVery inflamed entire face, with multiple nodules

Score 2: Jawline Acne Severity

ScoreSeverityFeatures
0NoneNo active lesions; may show erythema or post-inflammatory hyperpigmentation
1RareRare papules, pustules, or comedones
2FewFew papules/pustules/comedones; < 25% of area involved; nodule/cyst may be present
3NumerousNumerous papules/pustules/comedones; ≥ 25% of area involved; ≥ 2 nodules/cysts may be present
Female Hormonal Acne Presentation Singapore
Adult female hormonal acne often appears as inflamed pimples and comedones along the jawline and neck, flaring around menstrual cycles.

 Diagnosis: Assessment

Moderate adult female acne associated with scarring

The diagnosis was made based on CA’s history, clinical presentation, and examination findings. Her acne was graded as moderate using the Adult Female Acne Scoring Tool (AFAST), with evidence of both inflammatory lesions and post-acne scarring.

Differential diagnoses were considered:

  • Fungal acne (Pityrosporum folliculitis) was ruled out because her lesions included comedones, had the typical morphology of acneiform papules and pustules and were not associated with itchiness, which is more characteristic of fungal involvement.
  • Rosacea was also excluded. Although rosacea can present with inflammatory papules and pustules, CA’s case included comedones, and there were no signs of telangiectasia (broken capillaries), persistent facial erythema, or blushing/flushing episodes.

Thus, the clinical picture was most consistent with moderate adult female hormonal acne with post-inflammatory hyperpigmentation and atrophic scarring.

Treatment Plan: Tailored Strategy

Given CA’s long-standing acne, its moderate severity, and her history of inadequate response to both oral antibiotics and topical therapies, a tailored management plan was discussed. The focus was on addressing the hormonal influence driving her breakouts, while simultaneously targeting inflammation, comedones, and scarring.

  • Oral therapy — Off-label use of oral spironolactone was proposed to reduce the hormonal stimulation of sebaceous glands. Combined oral contraceptives were not considered, as they are contraindicated in women over 35 years of age who smoke, due to the increased risk of cardiovascular complications. After counselling on potential benefits and risks, CA opted to start on a low dose of spironolactone (50 mg/day), as she was cautious about tolerability. Reported side effects of spironolactone include menstrual irregularities, dizziness, headaches, breast tenderness, and nausea.
  • Topical therapy — Concurrent topical retinoids were prescribed to help reduce comedones, control inflammation and improve post-acne scarring over time. CA was counselled on correct application techniques and the need for gradual introduction to minimise irritation.
  • Lifestyle and skin care — She was educated on lifestyle modifications, including smoking cessation, stress management and avoidance of cosmetic triggers. Regular use of broad-spectrum sunscreen was emphasised, as retinoid therapy can increase photosensitivity, and because sun protection helps reduce post-inflammatory hyperpigmentation.

This multi-pronged plan aimed to provide both immediate acne control and long-term skin health, while respecting CA’s preferences and safety considerations.

Results and Outcome: The Transformation

CA was reviewed at monthly intervals to monitor her acne, treatment response, and any side effects from therapy.

  • First month — At the initial follow-up, there was little visible improvement; her acne remained inflamed. However, she reported no side effects from oral spironolactone. With topical retinoids, she experienced temporary dryness and redness, which were expected and managed with gradual introduction. Her oral spironolactone dose was subsequently increased to 100 mg/day for improved efficacy.
  • Third month — By the third visit, there was noticeable improvement. The majority of her inflammatory lesions had subsided, and she continued to tolerate spironolactone well, with no adverse effects. By this stage, she was also using topical retinoids comfortably without irritation.
  • Sixth month — At six months, CA showed minimal inflammatory and comedonal lesions, with a marked reduction in breakouts. Her post-inflammatory hyperpigmentation and scarring appeared significantly lighter, giving her skin a clearer and healthier appearance. Importantly, she expressed high satisfaction with her progress, reporting that she felt more in control of her skin health and experienced an overall improvement in quality of life.

Discussion: Insights

The management of adult female acne requires a holistic, individualised approach, as this condition often persists for years and significantly affects quality of life. Unlike adolescent acne, adult female acne tends to be inflammatory, deep-seated, and localised to the lower face, chin and jawline. It is commonly influenced by hormonal fluctuations, stress and lifestyle factors, which makes long-term strategies essential.

  • Multifaceted treatment plans — Effective care involves addressing all contributing factors simultaneously. This often means combining systemic and topical therapies tailored to the patient’s needs.
  • Hormonal therapies — Treatments such as spironolactone or oral contraceptives can help manage hormonally driven acne, even when hormone levels are within the normal range. These options are particularly useful for long-term management and as an alternative to prolonged antibiotic use.
  • Topical agents — Retinoids (including tretinoin, adapalene, and trifarotene) remain the primary treatment option for preventing clogged pores and improving cell turnover. Benzoyl peroxide is a valuable adjunct due to its antibacterial action and role in reducing antibiotic resistance. Azelaic acid is a suitable option for sensitive skin and also helps with post-inflammatory hyperpigmentation.
  • Limiting oral antibiotics — While oral antibiotics can be helpful in moderate to severe acne, their duration should be restricted to minimise the risk of bacterial resistance.
  • Addressing underlying factors — Lifestyle plays a significant role. Stress management, dietary adjustments and appropriate skincare routines are integral to sustained improvement.
  • Isotretinoin — For severe, scarring, or treatment-resistant acne, isotretinoin remains one of the most effective options. However, it requires strict monitoring due to its potential side effects and is usually reserved for carefully selected patients.

This case highlights that success in adult female hormonal acne is best achieved through a personalised, layered treatment strategy that balances efficacy, safety, and long-term maintenance.

Conclusion: Summarising the Success

CA’s journey highlights how adult female hormonal acne can persist despite standard therapies and significantly affect confidence and quality of life. By tailoring her treatment to address the hormonal component with spironolactone, while supporting her skin with retinoids, lifestyle adjustments, and regular follow-up, we achieved steady improvement and long-term control. Within six months, she experienced a marked reduction in breakouts, fading of scars and pigmentation, and regained confidence in her appearance. This case underscores the value of a personalised, holistic approach that balances efficacy, safety, and patient preference in achieving lasting results.

If you are struggling with persistent hormonal acne, schedule a consultation with APAX Medical & Aesthetic Clinic for expert diagnosis and a customised treatment plan designed to restore clear and healthy skin.

References:

  • Bagatin E, Freitas TH, Rivitti-Machado MC, Ribeiro BM, Nunes S, Rocha MA. Adult female acne: a guide to clinical practice. Anais brasileiros de dermatologia. 2019;94(01):62-75. 
  • Tanghetti EA, Kawata AK, Daniels SR, Yeomans K, Burk CT, Callender VD. Understanding the burden of adult female acne. J Clin Aesthet Dermatol. 2014;7:22–30. 
  • Auffret N, Claudel JP, Leccia MT, Poli F, Farhi D, Dréno B. AFAST–Adult Female Acne Scoring Tool: an easy‐to‐use tool for scoring acne in adult females. Journal of the European Academy of Dermatology and Venereology. 2016 May;30(5):824-8.
  • Reynolds RV, Yeung H, Cheng CE, Cook-Bolden F, Desai SR, Druby KM, Freeman EE, Keri JE, Gold LF, Tan JK, Tollefson MM. Guidelines of care for the management of acne vulgaris. Journal of the American Academy of Dermatology. 2024 May 1;90(5):1006-e1.

Disclaimer

All patient details have been anonymised to protect privacy, and no real names or initials are used. Any resemblance to actual persons is purely coincidental. Images included are for illustrative purposes only. Treatment outcomes vary between individuals, and the results described in this case study should not be taken as a guarantee of similar results. This content is intended for educational and informational purposes only and should not be considered medical advice. Patients are advised to consult a qualified healthcare professional for personalised diagnosis and treatment.

About Dr Moses Ng

MBBS (London) with distinction
Dip Practical Dermatology (Cardiff) with distinction
Member of American Acne & Rosacea Society
Fellow of American Society for Laser Medicine & Surgery

Dr. Moses Ng is a distinguished professional in the field of aesthetic medicine, renowned for his expertise in advanced cosmetic procedures. With over 15 years of experience, extensive training and a keen eye for detail, Dr. Ng specializes in a wide range of treatments, including injectables, laser therapies, and acne scar management.

Dr. Moses Ng’s commitment to excellence and patient-centric approach have earned him a reputation as a trusted clinician in aesthetic medicine. His continuous pursuit of the latest advancements in the field ensures that his patients receive the highest standard of care and the most effective treatments available.

read more

Request a Callback!

Please note: Patients are advised to consult a qualified medical professional to determine the right and suitable treatment option for their individual needs.
Get in touch with us with any questions, pricing, or bookings.
Please kindly contact us for details.





    @APAX Medical & Aesthetics Clinic 2025. All Rights Reserved.
    exit